Skip to main content
. 2022 Nov 7;27(1):249–258. doi: 10.1080/13510002.2022.2139947

Figure 6.

Figure 6.

Immunohistopathological examination for α-SMA expression in kidney tissues. (A) The score of α-SMA in all studied groups, (B) negative expression for α-SMA (control group, 400×), (C) marked cytoplasmic expression for α-SMA in both renal tubules and glomeruli (CKD group, 200×), (D) moderate expression of α-SMA in SPL group (200×), (E) mild expression of α-SMA in ZnO-NPs group (200×), and (F) mild expression in SPL + ZnO-NPs group (200×). a: significant difference versus control, b: significant versus CKD, c: significant versus SPL, d: significant versus ZnO-NPs at p < 0.05.